nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—HTR2C—Sorafenib—thyroid cancer	0.197	0.542	CbGbCtD
Methotrimeprazine—CYP1A2—Sorafenib—thyroid cancer	0.0716	0.197	CbGbCtD
Methotrimeprazine—CYP2D6—Sorafenib—thyroid cancer	0.059	0.162	CbGbCtD
Methotrimeprazine—Necrotising colitis—Epirubicin—thyroid cancer	0.0366	0.178	CcSEcCtD
Methotrimeprazine—CYP2D6—Doxorubicin—thyroid cancer	0.0358	0.0986	CbGbCtD
Methotrimeprazine—Necrotising colitis—Doxorubicin—thyroid cancer	0.0338	0.165	CcSEcCtD
Methotrimeprazine—Sudden death—Vandetanib—thyroid cancer	0.033	0.161	CcSEcCtD
Methotrimeprazine—Drug interaction—Sorafenib—thyroid cancer	0.0123	0.0598	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00968	0.0471	CcSEcCtD
Methotrimeprazine—Jaundice—Sorafenib—thyroid cancer	0.00622	0.0302	CcSEcCtD
Methotrimeprazine—Constipation—Vandetanib—thyroid cancer	0.00516	0.0251	CcSEcCtD
Methotrimeprazine—Liver injury—Epirubicin—thyroid cancer	0.00501	0.0244	CcSEcCtD
Methotrimeprazine—Liver injury—Doxorubicin—thyroid cancer	0.00464	0.0225	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Epirubicin—thyroid cancer	0.00422	0.0205	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0039	0.019	CcSEcCtD
Methotrimeprazine—Photosensitivity—Epirubicin—thyroid cancer	0.00349	0.0169	CcSEcCtD
Methotrimeprazine—Constipation—Sorafenib—thyroid cancer	0.00348	0.0169	CcSEcCtD
Methotrimeprazine—Photosensitivity—Doxorubicin—thyroid cancer	0.00322	0.0157	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Sorafenib—thyroid cancer	0.003	0.0146	CcSEcCtD
Methotrimeprazine—CHRM4—head—thyroid cancer	0.0029	0.0578	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.0028	0.0136	CcSEcCtD
Methotrimeprazine—DRD3—head—thyroid cancer	0.00269	0.0538	CbGeAlD
Methotrimeprazine—CHRM1—saliva-secreting gland—thyroid cancer	0.00261	0.0522	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00259	0.0126	CcSEcCtD
Methotrimeprazine—DRD5—head—thyroid cancer	0.00253	0.0504	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00241	0.0117	CcSEcCtD
Methotrimeprazine—Weight increased—Epirubicin—thyroid cancer	0.00241	0.0117	CcSEcCtD
Methotrimeprazine—Drowsiness—Epirubicin—thyroid cancer	0.00236	0.0115	CcSEcCtD
Methotrimeprazine—CHRM3—saliva-secreting gland—thyroid cancer	0.00234	0.0467	CbGeAlD
Methotrimeprazine—Jaundice—Epirubicin—thyroid cancer	0.0023	0.0112	CcSEcCtD
Methotrimeprazine—CHRM5—head—thyroid cancer	0.00227	0.0452	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00223	0.0109	CcSEcCtD
Methotrimeprazine—Weight increased—Doxorubicin—thyroid cancer	0.00223	0.0108	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Epirubicin—thyroid cancer	0.0022	0.0107	CcSEcCtD
Methotrimeprazine—Drowsiness—Doxorubicin—thyroid cancer	0.00218	0.0106	CcSEcCtD
Methotrimeprazine—Jaundice—Doxorubicin—thyroid cancer	0.00213	0.0103	CcSEcCtD
Methotrimeprazine—ADRA1B—head—thyroid cancer	0.00207	0.0413	CbGeAlD
Methotrimeprazine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00204	0.0099	CcSEcCtD
Methotrimeprazine—ADRA1D—head—thyroid cancer	0.00202	0.0404	CbGeAlD
Methotrimeprazine—CHRM1—trachea—thyroid cancer	0.00202	0.0402	CbGeAlD
Methotrimeprazine—DRD1—head—thyroid cancer	0.00193	0.0385	CbGeAlD
Methotrimeprazine—HTR2A—neck—thyroid cancer	0.00178	0.0355	CbGeAlD
Methotrimeprazine—ADRA2C—trachea—thyroid cancer	0.00158	0.0315	CbGeAlD
Methotrimeprazine—CHRM2—head—thyroid cancer	0.00155	0.031	CbGeAlD
Methotrimeprazine—HTR2C—head—thyroid cancer	0.0015	0.0299	CbGeAlD
Methotrimeprazine—Tachycardia—Epirubicin—thyroid cancer	0.00147	0.00714	CcSEcCtD
Methotrimeprazine—CHRM3—thyroid gland—thyroid cancer	0.00143	0.0285	CbGeAlD
Methotrimeprazine—CHRM1—head—thyroid cancer	0.00142	0.0282	CbGeAlD
Methotrimeprazine—Tachycardia—Doxorubicin—thyroid cancer	0.00136	0.0066	CcSEcCtD
Methotrimeprazine—Somnolence—Epirubicin—thyroid cancer	0.00134	0.0065	CcSEcCtD
Methotrimeprazine—Constipation—Epirubicin—thyroid cancer	0.00129	0.00625	CcSEcCtD
Methotrimeprazine—HRH1—trachea—thyroid cancer	0.00128	0.0256	CbGeAlD
Methotrimeprazine—CHRM3—head—thyroid cancer	0.00127	0.0253	CbGeAlD
Methotrimeprazine—ADRA2A—trachea—thyroid cancer	0.00126	0.0251	CbGeAlD
Methotrimeprazine—Somnolence—Doxorubicin—thyroid cancer	0.00124	0.00602	CcSEcCtD
Methotrimeprazine—Constipation—Doxorubicin—thyroid cancer	0.00119	0.00579	CcSEcCtD
Methotrimeprazine—ADRA1A—head—thyroid cancer	0.00116	0.0232	CbGeAlD
Methotrimeprazine—DRD2—head—thyroid cancer	0.00114	0.0227	CbGeAlD
Methotrimeprazine—Hypersensitivity—Epirubicin—thyroid cancer	0.00111	0.00539	CcSEcCtD
Methotrimeprazine—ADRA2C—head—thyroid cancer	0.00111	0.0221	CbGeAlD
Methotrimeprazine—CYP1A2—thyroid gland—thyroid cancer	0.00108	0.0216	CbGeAlD
Methotrimeprazine—HTR2A—trachea—thyroid cancer	0.00107	0.0214	CbGeAlD
Methotrimeprazine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00103	0.00499	CcSEcCtD
Methotrimeprazine—ADRA2A—thyroid gland—thyroid cancer	0.000997	0.0199	CbGeAlD
Methotrimeprazine—CYP2E1—thyroid gland—thyroid cancer	0.000975	0.0195	CbGeAlD
Methotrimeprazine—HRH1—head—thyroid cancer	0.0009	0.018	CbGeAlD
Methotrimeprazine—ADRA2A—head—thyroid cancer	0.000884	0.0176	CbGeAlD
Methotrimeprazine—CYP2E1—head—thyroid cancer	0.000865	0.0173	CbGeAlD
Methotrimeprazine—ADRA2C—lymph node—thyroid cancer	0.000776	0.0155	CbGeAlD
Methotrimeprazine—HTR2A—head—thyroid cancer	0.000752	0.015	CbGeAlD
Methotrimeprazine—CYP2D6—head—thyroid cancer	0.000685	0.0137	CbGeAlD
Methotrimeprazine—HRH1—lymph node—thyroid cancer	0.00063	0.0126	CbGeAlD
Methotrimeprazine—ADRA2A—lymph node—thyroid cancer	0.000619	0.0124	CbGeAlD
Methotrimeprazine—CHRM3—Signaling Pathways—HIF1A—thyroid cancer	7.36e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	7.33e-05	0.000192	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	7.29e-05	0.000191	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	7.27e-05	0.000191	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	7.21e-05	0.000189	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—HRAS—thyroid cancer	7.16e-05	0.000188	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	7.15e-05	0.000188	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—RXRA—thyroid cancer	7.09e-05	0.000186	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	7.08e-05	0.000186	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	7.06e-05	0.000185	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—HRAS—thyroid cancer	7.06e-05	0.000185	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	6.96e-05	0.000183	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	6.89e-05	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PPARG—thyroid cancer	6.87e-05	0.00018	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—AKT1—thyroid cancer	6.86e-05	0.00018	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	6.78e-05	0.000178	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—HRAS—thyroid cancer	6.76e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	6.76e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	6.75e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—KRAS—thyroid cancer	6.74e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CCND1—thyroid cancer	6.71e-05	0.000176	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—AKT1—thyroid cancer	6.7e-05	0.000176	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.7e-05	0.000176	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—thyroid cancer	6.65e-05	0.000175	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	6.65e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CCND1—thyroid cancer	6.62e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—AKT1—thyroid cancer	6.57e-05	0.000173	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	6.54e-05	0.000172	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	6.53e-05	0.000171	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	6.51e-05	0.000171	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	6.49e-05	0.00017	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	6.48e-05	0.00017	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PTEN—thyroid cancer	6.48e-05	0.00017	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	6.44e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	6.42e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	6.41e-05	0.000168	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PTEN—thyroid cancer	6.39e-05	0.000168	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	6.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—HRAS—thyroid cancer	6.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CCND1—thyroid cancer	6.34e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—AKT1—thyroid cancer	6.32e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PPARG—thyroid cancer	6.31e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	6.31e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	6.26e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—BRAF—thyroid cancer	6.25e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	6.23e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	6.21e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	6.18e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	6.18e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	6.15e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—BRAF—thyroid cancer	6.14e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PTEN—thyroid cancer	6.12e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—BRAF—thyroid cancer	6.12e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—BRAF—thyroid cancer	6.1e-05	0.00016	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CCND1—thyroid cancer	6.04e-05	0.000159	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	6.04e-05	0.000158	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	6.02e-05	0.000158	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—RXRA—thyroid cancer	6.01e-05	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—thyroid cancer	5.99e-05	0.000157	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	5.97e-05	0.000157	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	5.96e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CCND1—thyroid cancer	5.96e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	5.95e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—thyroid cancer	5.89e-05	0.000155	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.84e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PTEN—thyroid cancer	5.83e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTEN—thyroid cancer	5.8e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—NRAS—thyroid cancer	5.78e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PTEN—thyroid cancer	5.75e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	5.75e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	5.74e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—HRAS—thyroid cancer	5.73e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	5.72e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—NRAS—thyroid cancer	5.7e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	5.69e-05	0.000149	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	5.63e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	5.62e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	5.61e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	5.61e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	5.6e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	5.59e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	5.58e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	5.58e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	5.53e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	5.51e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	5.51e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NRAS—thyroid cancer	5.46e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—thyroid cancer	5.4e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	5.38e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	5.36e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	5.36e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	5.28e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	5.21e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NRAS—thyroid cancer	5.2e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	5.19e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	5.17e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTEN—thyroid cancer	5.14e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	5.13e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NRAS—thyroid cancer	5.13e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	5.13e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	5.12e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	5.07e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—thyroid cancer	5.06e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	5.03e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	4.99e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—KRAS—thyroid cancer	4.97e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—thyroid cancer	4.96e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	4.95e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—KRAS—thyroid cancer	4.91e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	4.87e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	4.86e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	4.85e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	4.79e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	4.78e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	4.77e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	4.76e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	4.74e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	4.73e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	4.73e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTEN—thyroid cancer	4.71e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	4.7e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—KRAS—thyroid cancer	4.7e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	4.69e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	4.66e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	4.65e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	4.64e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	4.63e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	4.63e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	4.61e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	4.57e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCND1—thyroid cancer	4.56e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	4.56e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	4.49e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCND1—thyroid cancer	4.48e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—KRAS—thyroid cancer	4.48e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—thyroid cancer	4.48e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	4.46e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	4.45e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCND1—thyroid cancer	4.45e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—thyroid cancer	4.42e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—KRAS—thyroid cancer	4.42e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	4.42e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	4.41e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PTEN—thyroid cancer	4.4e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	4.39e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—thyroid cancer	4.36e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	4.35e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	4.33e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	4.33e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTEN—thyroid cancer	4.33e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PTEN—thyroid cancer	4.32e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	4.31e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	4.29e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PTEN—thyroid cancer	4.29e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	4.26e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	4.25e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	4.24e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	4.23e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HRAS—thyroid cancer	4.23e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	4.23e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	4.22e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	4.2e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	4.19e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—thyroid cancer	4.18e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HRAS—thyroid cancer	4.17e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	4.15e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	4.14e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	4.08e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HRAS—thyroid cancer	3.99e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	3.99e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—thyroid cancer	3.98e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	3.94e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NRAS—thyroid cancer	3.93e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	3.93e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—thyroid cancer	3.93e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	3.86e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NRAS—thyroid cancer	3.86e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	3.84e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	3.84e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NRAS—thyroid cancer	3.83e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	3.83e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HRAS—thyroid cancer	3.81e-05	9.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	3.79e-05	9.96e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—thyroid cancer	3.79e-05	9.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	3.78e-05	9.93e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HRAS—thyroid cancer	3.75e-05	9.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	3.75e-05	9.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—thyroid cancer	3.73e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	3.73e-05	9.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—thyroid cancer	3.68e-05	9.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	3.67e-05	9.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	3.54e-05	9.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—thyroid cancer	3.53e-05	9.25e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.52e-05	9.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	3.52e-05	9.23e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—thyroid cancer	3.4e-05	8.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	3.39e-05	8.9e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—KRAS—thyroid cancer	3.38e-05	8.87e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—thyroid cancer	3.36e-05	8.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—thyroid cancer	3.34e-05	8.78e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	3.33e-05	8.73e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—KRAS—thyroid cancer	3.32e-05	8.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	3.32e-05	8.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—thyroid cancer	3.32e-05	8.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	3.31e-05	8.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	3.31e-05	8.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—KRAS—thyroid cancer	3.3e-05	8.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	3.27e-05	8.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	3.26e-05	8.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	3.26e-05	8.55e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	3.26e-05	8.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	3.17e-05	8.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	3.12e-05	8.18e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTEN—thyroid cancer	3.07e-05	8.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	3.03e-05	7.94e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—thyroid cancer	3e-05	7.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	2.99e-05	7.86e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.98e-05	7.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—thyroid cancer	2.96e-05	7.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—thyroid cancer	2.96e-05	7.76e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—thyroid cancer	2.95e-05	7.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—thyroid cancer	2.94e-05	7.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—thyroid cancer	2.93e-05	7.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—thyroid cancer	2.9e-05	7.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	2.89e-05	7.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	2.87e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HRAS—thyroid cancer	2.87e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	2.83e-05	7.42e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HRAS—thyroid cancer	2.82e-05	7.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	2.81e-05	7.38e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HRAS—thyroid cancer	2.8e-05	7.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	2.8e-05	7.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	2.78e-05	7.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	2.77e-05	7.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	2.75e-05	7.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—thyroid cancer	2.72e-05	7.13e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	2.69e-05	7.06e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTEN—thyroid cancer	2.6e-05	6.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	2.57e-05	6.75e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—thyroid cancer	2.54e-05	6.66e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	2.5e-05	6.55e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—thyroid cancer	2.49e-05	6.55e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—thyroid cancer	2.49e-05	6.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	2.48e-05	6.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—thyroid cancer	2.47e-05	6.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	2.45e-05	6.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	2.44e-05	6.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	2.27e-05	5.96e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—thyroid cancer	1.77e-05	4.64e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—thyroid cancer	1.5e-05	3.93e-05	CbGpPWpGaD
